Semantic Dementia
16
5
6
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Intervention for Communication Quality of Life in Primary Progressive Aphasia
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Treatment for Speech and Language in Primary Progressive Aphasia
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Primary Progressive Aphasia Multicomponent Language Treatment Study
The Swedish BioFINDER 2 Study
Diagnosing Frontotemporal Lobar Degeneration
Home-Based Exercise in Primary Progressive Aphasia (HEPPA)
Memory and Social Interactions
Revealing Engagement Dynamics Among Semantic Dementia Patients
Evaluation of a Transcranial Stimulation With Direct Current on Language Disorders in Semantic Dementia
Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
PiB PET Scanning in Speech and Language Based Dementias
Language Treatment for Progressive Aphasia